Dr. Judith L. Toffenetti and Paul Skwierawski Join Kacvinsky Daisak Bluni

Judith Toffenetti

Judith Toffenetti

National intellectual property firm Kacvinsky Daisak Bluni PLLC recently expanded its legal team in the Washington, D.C. area with the arrivals of experienced IP lawyers, Judith L. Toffenetti, PhD and Paul Skwierawski. Toffenetti joins as a partner, bringing decades of experience in life sciences and biotechnology. Skwierawski joins as counsel, focusing on prosecution of medical portables and construction equipment technologies. Their arrivals mark KDB’s fifth and sixth hires within a year.

With decades of experience in patent portfolio management and strategy in areas such as small molecule therapies, genomics, gene therapy, anti-cancer therapies, molecular biology, immunology and pharmaceutical formulations,Toffenetti joins KDB from McDermott Will & Emery, where she was a partner. Her practice also focuses on patent prosecution, licensing and strategic client counseling. Skwierawski joins the D.C. office from Jones Robb PLLC, bringing several years of experience in medical and construction equipment patent application and prosecution, to serve as counsel for KDB partners and clientele.

“We are excited to have Judith and Paul join the team in our Washington D.C. office,” said Scott Bluni, KDB partner and Chief Operating Officer. “Judith’s vast experience and wealth of knowledge in the life sciences and biotechnology fields will add great value to the firm clients. Paul is an exceptional addition to our D.C. office, where his impressive experience and dedication will serve our organization well, and provide high-level counsel to our clients.”

Paul Skwierawski

Paul Skwierawski

KDB’s inter-connected operating structure and team of highly experienced IP talent attracted both lawyers to the now 31-attorney firm.

“It’s a great opportunity for both KDB and myself,” said Toffenetti, noting that she will work closely  with emerging pharmaceutical and biotechnology companies, universities and research institutes specializing in the biotech and medical fields. “As I initially started in a boutique firm, I had a desire to go back to my roots, and KDB was the perfect firm that helps foster the type of innovation and collaboration I was seeking.”

Prior to joining McDermott Will & Emery, Toffenetti was a post-doctoral fellow at MIT, where she conducted research in the molecular biology of Drosophila myogenesis. Previously, she conducted molecular genetics research in the area of retinal degeneration at the Eye Institute of the National Institutes of Health for five years. A graduate of George Washington University Law School, Toffenetti holds a bachelor’s degree in biology and a master’s degree in microbial molecular biology.

Previously, Skwierawski was the manager and main point of contact of incoming work for a major Japanese client. With his experience, he holds MPEP [Manual of Patent Examining Procedure] lecture seminars for foreign-based trainees in Washington D.C. Skwierawski graduated with a J.D. from Franklin Pierce Law Center and received a B.S. in electrical engineering technology from Southeastern Massachusetts University.

About Kacvinsky Daisak Bluni

Kacvinsky Daisak Bluni PLLC is a full-service intellectual property law firm focused on providing clients with the best IP attorneys regardless of their location. Founded in 2003 by John Kacvinsky, formerly with an Am Law 100 firm and Intel Corp.’s in-house team, KDB was among the nation’s first law firms to focus exclusively on recruiting and retaining talent regardless of location. Through a well-connected network of attorneys nationwide, KDB keeps overhead low and client rates competitive while recruiting experienced IP counsel, most of whom were former in-house counsel, scientists and engineers. With a 30-lawyer network throughout the United States and in dedicated and efficient shared-space offices in Massachusetts, New Jersey, North Carolina and Washington, D.C., KDB’s scope is unlimited with clients ranging from start-ups to universities to global Fortune 20 companies.


Warning & Disclaimer: The pages, articles and comments on IPWatchdog.com do not constitute legal advice, nor do they create any attorney-client relationship. The articles published express the personal opinion and views of the author as of the time of publication and should not be attributed to the author’s employer, clients or the sponsors of IPWatchdog.com. Read more.

Join the Discussion

No comments yet.